WESTERN STANDARD LLC Merrimack Pharmaceuticals, Inc. Transaction History

WESTERN STANDARD LLC portfolio value:

$4.39M
portfolio value

WESTERN STANDARD LLC quarter portfolio value change:

-36.97%
quarter

Merrimack Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -7.65% -97.09K shares -3.15M $3.75 1.17M
Q2 2022 share Increase +8.28% 97.09K shares 754K $5.95 1.26M
Q1 2022 share 0.00% 0 shares 2.21M $6.33 1.17M
Q4 2021 share Decrease -7.65% -97.09K shares -1.54M $3.93 1.17M
Q3 2021 share 0.00% 0 shares -1.98M $4.83 1.26M
Q2 2021 share Increase +25.50% 257.98K shares 1.75M $6.39 1.26M
Q1 2021 share 0.00% 0 shares -617K $6.28 1.01M
Q4 2020 share Decrease -4.86% -51.69K shares 2.71M $6.89 1.01M
Q3 2020 share Increase +22.31% 193.91K shares 1.35M $4 1.06M
Q2 2020 share Increase +3.14% 26.44K shares 1.08M $3.33 869.35K
Q1 2020 share 0.00% 0 shares -843K $2.15 842.91K
Q4 2019 share 0.00% 0 shares -1.13M $3.15 842.91K
Q3 2019 share Increase +6.15% 48.84K shares 13K $3.98 842.91K
Q2 2019 share Increase +46.88% 253.43K shares 824K $3.32 794.06K
Q1 2019 share Increase +182.89% 349.52K shares 2.37M $3.82 540.63K
Q4 2018 share Increase 0.00% 191.11K shares 580K $2.12 191.11K